155 related articles for article (PubMed ID: 36855845)
21. Morphological and morphometric analysis of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a retrospective study.
Filoni A; Cicco G; Lospalluti L; Maglietta A; Foti C; Annichiarico G; Resta L; Bonamonte D
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1707-1714. PubMed ID: 31692111
[TBL] [Abstract][Full Text] [Related]
22. [Squamous cell carcinoma complicating an hereditary epidermolysis bullosa].
Mseddi M; Turki H; Marrekchi S; Abdelmaksoud W; Masmoudi A; Bouassida S; Zahaf A
Cancer Radiother; 2004 Aug; 8(4):266-9. PubMed ID: 15450521
[TBL] [Abstract][Full Text] [Related]
23. Malignant melanoma and a squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Chorny JA; Shroyer KR; Golitz LE
Arch Dermatol; 1993 Sep; 129(9):1212. PubMed ID: 8363416
[No Abstract] [Full Text] [Related]
24. Expression of mutant p53 gene in squamous carcinoma arising in patients with recessive dystrophic epidermolysis bullosa.
Slater SD; McGrath JA; Hobbs C; Eady RA; McKee PH
Histopathology; 1992 Mar; 20(3):237-41. PubMed ID: 1563710
[TBL] [Abstract][Full Text] [Related]
25. [Generalized dystrophic epidermolysis bullosa and development of squamous cell carcinoma].
Petersen RB; Bonde CT; Schmidt G
Ugeskr Laeger; 2010 Nov; 172(47):3267-8. PubMed ID: 21092724
[TBL] [Abstract][Full Text] [Related]
26. Electrochemotherapy, a potential new treatment for the management of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: report of three cases.
Diociaiuti A; Rotunno R; El Hachem M; Latorre S; Cozza R; Curatolo P
J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1195-6. PubMed ID: 25758658
[No Abstract] [Full Text] [Related]
27. Genetic Profiles of Squamous Cell Carcinomas Associated with Recessive Dystrophic Epidermolysis Bullosa Unveil NOTCH and TP53 Mutations and an Increased MYC Expression.
Sans-DeSanNicolas L; Caratú G; Vidal-Cortés O; Sanchez-Redondo S; Ferrer B; Mancuso F; González-Sanchez E; Pérez-Alea M; McGrail K; Hernandez-Losa J; Bodet D; Vivancos A; Garcia-Patos V; Recio JA
J Invest Dermatol; 2018 Jun; 138(6):1423-1427. PubMed ID: 29291383
[No Abstract] [Full Text] [Related]
28. Cadaveric allograft for wound closure after resection of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a report of 32 resections and repairs in 2 patients.
Buonocore SD; Ariyan S
Ann Plast Surg; 2009 Sep; 63(3):297-9. PubMed ID: 19692898
[TBL] [Abstract][Full Text] [Related]
29. Pruritus Anesis in Dystrophic Epidermolysis Bullosa Pruriginosa with Dupilumab.
Yang DY; Jing WW; Liu X; Li L; Lu T; Li XL
Adv Skin Wound Care; 2024 Feb; 37(2):1-4. PubMed ID: 38241457
[TBL] [Abstract][Full Text] [Related]
30. Sentinel lymph node biopsy in recessive dystrophic epidermolysis bullosa and squamous cell carcinoma.
Perez-Naranjo L; Herrera-Saval A; Garcia-Bravo B; Perez-Bernal AM; Camacho F
Arch Dermatol; 2005 Jan; 141(1):110-1. PubMed ID: 15655164
[No Abstract] [Full Text] [Related]
31. Squamous cell carcinoma in epidermolysis bullosa. Treatment with systemic chemotherapy.
Lentz SR; Raish RJ; Orlowski EP; Marion JM
Cancer; 1990 Sep; 66(6):1276-8. PubMed ID: 2205357
[TBL] [Abstract][Full Text] [Related]
32. Metastatic squamous cell carcinoma resembling angiosarcoma complicating dystrophic epidermolysis bullosa.
McGrath JA; Schofield OM; Mayou BJ; McKee PH; Eady RA
Dermatologica; 1991; 182(4):235-8. PubMed ID: 1884860
[TBL] [Abstract][Full Text] [Related]
33. Squamous cell carcinoma developing in epidermolysis bullosa dystrophica.
Yoshioka K; Kono T; Kitajima J; Nakagawa K; Yashiro N; Taniguchi S; Furukawa M; Hamada T
Int J Dermatol; 1991 Oct; 30(10):718-21. PubMed ID: 1955228
[TBL] [Abstract][Full Text] [Related]
34. [Squamous cell cancers in Hallopeau-Siemens recessive dystrophic epidermolysis bullosa].
Otte HG; Stieler W; Anton-Lamprecht I
Hautarzt; 1990 Sep; 41(9):494-8. PubMed ID: 2249946
[TBL] [Abstract][Full Text] [Related]
35. Successful forearm prosthesis fitting in a patient with epidermolysis bullosa dystrophica: Case report.
Verduyn C; Morren MA; Stas M; Sinnaeve F; Segers K; Kiekens C
Prosthet Orthot Int; 2018 Jun; 42(3):254-257. PubMed ID: 28726572
[TBL] [Abstract][Full Text] [Related]
36. Treatment of skin cancers in epidermolysis bullosa.
Venugopal SS; Murrell DF
Dermatol Clin; 2010 Apr; 28(2):283-7, ix-x. PubMed ID: 20447493
[TBL] [Abstract][Full Text] [Related]
37. Successful use of rituximab, an anti-CD20 monoclonal antibody, to treat IgA nephropathy in a patient with recessive dystrophic epidermolysis bullosa.
Hunjan MK; Bardhan A; Harper N; Langman G; Ajayi B; Suresh V; Heagerty AHM
Clin Exp Dermatol; 2022 Aug; 47(8):1588-1590. PubMed ID: 35426452
[TBL] [Abstract][Full Text] [Related]
38. [Cutaneous squamous cell carcinomas: a complication of severe forms of hereditary epidermolysis bullosa].
Bourrat E
Soins; 2023 Nov; 68(880):36-38. PubMed ID: 37931996
[TBL] [Abstract][Full Text] [Related]
39. Free anterolateral thigh perforator flap for reconstruction of dystrophic epidermolysis bullosa-associated squamous cell carcinoma in the foot: case report.
Hsieh CH; Kuo YR; Huang PH; Jeng SF
Ann Plast Surg; 2003 Feb; 50(2):201-3. PubMed ID: 12567061
[TBL] [Abstract][Full Text] [Related]
40. Epidermolysis bullosa dystrophica of Hallopeau-Siemens and squamous-cell carcinoma: a case report.
Van Rengen A; Degreef H
Dermatology; 1996; 192(4):418-9. PubMed ID: 8864399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
